Search results
3.6 million Medicare enrollees may now be eligible for Wegovy coverage
WTAE Pittsburgh· 7 days agoAbout 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy,...
As Medicare Part D grows, so does need for fraud audits
BenefitsPRO· 6 days agoCMS is required to audit the financial records of at least one-third of Part D plan sponsors...
The Unfortunate Truth About Claiming Social Security at Age 70
Motley Fool via Yahoo Finance· 3 days agoThere...lifetime income from Social Security. You'll have to pay for Medicare out-of-pocket If...
TONI SAYS: Why is Medicare Part D’s IRMAA premium so high?
Odessa American· 7 days agoIf I do not apply for a Medicare prescription drug plan, do I still have to pay the “extra” $33.30? Does applying for a Medicare Advantage plan including ...
What is the Medicare Donut Hole and What Are Your Options?
Penny Hoarder via AOL· 4 days agoMedicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...
Millions of Medicare recipients could gain access to weight-loss drug
Newsweek· 7 days agoMillions of overweight or obese patients with heart conditions insured under Medicare could gain...
Are you a Medicare, Social Security recipient planning a move? Here's what you should know
The Oklahoman via Yahoo News· 20 hours agoIf you tell your plan after you move, your chance to switch plans begins the month you tell your...
Over 70% of Low-Income Women Have No Confidence in Their Ability To Plan for Retirement — 8...
GOBankingRates via Yahoo Finance· 7 hours agoWe support the Treat and Reduce Obesity Act (TROA), which is a bipartisan bill designed to ensure...
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 hours agoThis increase in gross-to-net deductions in the first quarter of 2024 is primarily related to higher Medicare Part D and PHS expenses ...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY via Yahoo Finance· 6 days agoFederal spending on these drugs is likely to grow, experts say. If just 1 in 10 eligible adults take...